by TractManager | Aug 26, 2020 | Health Technology Assessment
Focus of the Report: This report focuses on matrix-induced autologous chondrocyte implantation (MACI) for the treatment of patients with chondral defects of the knee.Technology Description: MACI is a multi-stage procedure that involves 2 surgeries. During an initial...
by TractManager | Aug 24, 2020 | Emerging Technology Report
Enspryng (satralizumab) is interleukin-6 (IL-6) receptor antagonist indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. It is administered by subcutaneous injection.If you...
by TractManager | Aug 19, 2020 | Health Technology Assessment
Focus of the Report: The use of deep brain stimulation (DBS) for treatment of refractory obsessive-compulsive disorder (OCD). Technology Description: DBS therapy uses mild electrical impulses to regulate electrical activity of neural circuits. Patients undergo surgery...
by TractManager | Aug 7, 2020 | Molecular Test Assessment
The report evaluates the analytical validity, clinical validity, and clinical utility of the FirstSightCRC test, a liquid biopsy test that detects and analyzes circulating tumor cells (CTCs) and is intended to predict the likelihood of having precancerous adenomatous...
by TractManager | Aug 6, 2020 | Health Technology Assessment
Focus of the Report: This report focuses on bioimpedance analysis (BIA) for diagnosis, predicting development, selection of treatment, and monitoring of lymphedema (LE).Technology Description: BIA measures the differential impedance (resistance) to low level...
Recent Comments